Canna Law Blog

JANUARY 11, 2022

The issue of enforcement or compliance is probably the biggest one most states face at the policy level. Today, we’ll look at the argument that a compliance focus is better than an enforcement focus. Despite all of this, some folks seem to think that prohibition and compliance is still the answer. compliance tradeoff.

Compliance 77

Compliance Compliance State Laws DEA 77

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. DEA and the Controlled Substances Act.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

SEPTEMBER 23, 2019

Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. Due to the Schedule I classification by the Drug Enforcement Agency (DEA), researchers seeking to investigate health effects associated with cannabis must follow a regimented application process.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Canna Law Blog

AUGUST 2, 2020

And it’s not so much the case anymore that the Drug Enforcement Administration (DEA) or Department of Justice (DOJ) are coming to knock down your door and arrest and prosecute you as a cannabis business owner for open violations of the federal Controlled Substances Act (CSA).

DEA 98

DEA Business Compliance Compliance 98